Literature DB >> 2567430

Variable expression of P fimbriae in Escherichia coli urinary tract infection.

M Lichodziejewska1, N Topley, R Steadman, R K Mackenzie, K V Jones, J D Williams.   

Abstract

Fresh urinary isolates were examined by immunofluorescence with polyclonal rabbit antibodies against type 1 and P fimbriae. This procedure showed P-fimbriate Escherichia coli in 22 of 24 samples from patients with asymptomatic bacteriuria, 24 of 26 samples from patients with cystitis, and 6 of 6 samples from patients with pyelonephritis. Type 1 fimbriae were expressed by less than 40% of isolates in all three groups. There was no relation between the presence of symptoms or the site of infection and fimbrial expression, of P or type 1, by bacteria adherent to freshly isolated uroepithelial cells.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2567430     DOI： 10.1016/s0140-6736(89)90125-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


  10 in total

Review 1.  Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.

Authors:  Thomas J Hannan; Makrina Totsika; Kylie J Mansfield; Kate H Moore; Mark A Schembri; Scott J Hultgren
Journal:  FEMS Microbiol Rev       Date:  2012-05       Impact factor: 16.408

2.  Frequency and organization of papA homologous DNA sequences among uropathogenic digalactoside-binding Escherichia coli strains.

Authors:  K Denich; A Craiu; H Rugo; G Muralidhar; P O'Hanley
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

3.  Escherichia coli serotype O15:K52:H1 as a uropathogenic clone.

Authors:  G Prats; F Navarro; B Mirelis; D Dalmau; N Margall; P Coll; A Stell; J R Johnson
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

4.  DNA sequences of three papA genes from uropathogenic Escherichia coli strains: evidence of structural and serological conservation.

Authors:  K Denich; L B Blyn; A Craiu; B A Braaten; J Hardy; D A Low; P D O'Hanley
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

Review 5.  Applications from bacterial adhesion and biofilm studies in relation to urogenital tissues and biomaterials: a review.

Authors:  G Reid
Journal:  J Ind Microbiol       Date:  1994-03

6.  Cell surface hydrophobicity, adherence to HeLa cell cultures and haemagglutination pattern of pyelonephritogenic Escherichia coli strains.

Authors:  A Brauner; M Katouli; K Tullus; S H Jacobson
Journal:  Epidemiol Infect       Date:  1990-10       Impact factor: 2.451

7.  P fimbriation of Escherichia coli strains from patients with urosepsis demonstrated by a commercial agglutination test (PF TEST).

Authors:  U Kärkkäinen; R Ikäheimo; M L Katila; R Mäntyjärvi
Journal:  J Clin Microbiol       Date:  1991-01       Impact factor: 5.948

Review 8.  Drug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections.

Authors:  Valerie P O'Brien; Thomas J Hannan; Hailyn V Nielsen; Scott J Hultgren
Journal:  Microbiol Spectr       Date:  2016-02

9.  Type 1 fimbriae contribute to catheter-associated urinary tract infections caused by Escherichia coli.

Authors:  Andreas Reisner; Mario Maierl; Michael Jörger; Robert Krause; Daniela Berger; Andrea Haid; Dijana Tesic; Ellen L Zechner
Journal:  J Bacteriol       Date:  2013-12-13       Impact factor: 3.490

10.  Escherichia coli global gene expression in urine from women with urinary tract infection.

Authors:  Erin C Hagan; Amanda L Lloyd; David A Rasko; Gary J Faerber; Harry L T Mobley
Journal:  PLoS Pathog       Date:  2010-11-11       Impact factor: 6.823
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.